Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: simultaneous activation of PPARalpha, PPARgamma, and PPARdelta.

Source:http://linkedlifedata.com/resource/pubmed/id/18220606

Download in:

View as

General Info

PMID
18220606